van der Laan J W, Weick G, Hillen F C
Psychopharmacology (Berl). 1983;81(3):267-71. doi: 10.1007/BF00427276.
The anti-withdrawal effect of clonidine was studied using quasi-morphine abstinence behaviour induced by dipropylacetate (DPA) in naive rats. Clonidine potently suppressed body shakes and locomotor activity (ID50 30 and 40 micrograms/kg IP respectively). Phenoxybenzamine and prazosine did not antagonize the anti-withdrawal effect of clonidine, whereas piperoxane and yohimbine were effective with respect to locomotor activity and a total abstinence score. Piperoxane also reversed the suppressive action of clonidine on body shakes. Other alpha 2-agonists (guanfacine, azepexole and BHT 920) also suppressed DPA-induced behaviour, whereas the lipophilic alpha 1-agonist ST-587 had such an effect only at high doses. The relative potencies of the alpha 2-agonists correlated well with their potency to exert other alpha 2-adrenoceptor mediated actions such as blood pressure lowering and sedation.
采用二丙乙酸(DPA)诱导未用药大鼠产生准吗啡戒断行为,研究可乐定的抗戒断作用。可乐定能有效抑制身体抖动和运动活动(腹腔注射的半数抑制剂量分别为30和40微克/千克)。酚苄明和哌唑嗪不能拮抗可乐定的抗戒断作用,而哌罗克生和育亨宾对运动活动和总体戒断评分有效。哌罗克生还能逆转可乐定对身体抖动的抑制作用。其他α2激动剂(胍法辛、阿泽哌唑和BHT 920)也能抑制DPA诱导的行为,而亲脂性α1激动剂ST-587只有在高剂量时才有此作用。α2激动剂的相对效价与其发挥其他α2肾上腺素能受体介导作用(如降低血压和镇静)的效价密切相关。